Metraipolis › archive › dc_e2e7989c69a3

Impact of chemotherapy and immunotherapy on survival in pediatric primary diffuse leptomeningeal melanomatosis: a systematic review and pooled survival analysis — Europe PMC PMID:42065770

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42065770
DOI
10.1007/s00381-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-02T20:03:45.897Z
SHA-256 of the archived text
edf6f8dfde8e3925bbb68c55850f5c85b59cca73dace258c510bfb4629d0edcb
Stable URL of this page
https://metraipolis.com/documento/dc_e2e7989c69a3

How to cite

Impact of chemotherapy and immunotherapy on survival in pediatric primary diffuse leptomeningeal melanomatosis: a systematic review and pooled survival analysis — Europe PMC PMID:42065770 — Europe PMC (en), https://europepmc.org/article/MED/42065770 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2e7989c69a3 (Metraipolis archive dc_e2e7989c69a3, sha256 edf6f8dfde8e3925bbb68c55850f5c85b59cca73dace258c510bfb4629d0edcb)
BibTeX
@misc{dce2e7989c69a3,
  title = {Impact of chemotherapy and immunotherapy on survival in pediatric primary diffuse leptomeningeal melanomatosis: a systematic review and pooled survival analysis — Europe PMC PMID:42065770},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42065770},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2e7989c69a3; sha256 edf6f8dfde8e3925bbb68c55850f5c85b59cca73dace258c510bfb4629d0edcb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42065770. Agents can read the archived copy with the MCP tool read_document.